The event will take place on February 25-26, 2021 in Paris, France, at La Maison de la Chimie and will demonstrate how personalised medicine will lead to the next generation of healthcare by 2030.
ECRIN's celebration of International Clinical Trials Day (ICTD) will be held on May 27th, 2021 in Berlin (Langenbeck-Virchow-Haus Berlin, Luisenstraße 58/59, 10117 Berlin, Germany). The topic will be (patient-)recruitment in clinical trials. More details to come!
Training: Clinical evaluation of medical devices: from the restrictions and obligations to the means and levers
The University Hospital of Nîmes, the F-CRIN approved Tech4Health service platform and the Education & Training Unit of F-CRIN's Coordination Office are organising the training course "Clinical evaluation of medical
The Clinical and Epidemiological Investigation Centre (CIEC) of the Luxembourg Institute of Health (LIH) is holding the LuxCLIN conference on 'eClinical Research: getting virtual and personal'. The event will take place on Tuesday, 30 and Wednesday 31 May 2017 at Centre Hospitalier Luxembourg (CHL) in Luxembourg.
The detailed program and guidelines for registration can be found on the LuxCLIN conference website
ECRIN's 2017 celebration of International Clinical Trials Day (ICTD) will take place in Lisbon, Portugal on 19 May 2017.
The theme of this year’s event is ‘Data sharing and reuse: attitudes and practices in multinational clinical research'.
The aim is to engage with the public, scientific community and decision makers on issues related to (multinational) clinical trials in Europe, and to address issues related to data sharing and re-use in particular.
University Claude Bernard Lyon - Eudipharm, OrphanDev (part of ECRIN's French national partner, the French Clinical Research Infrastructure Network or F-CRIN), and F-CRIN's training and education unit are co-organising the 4th edition of the training course on 'Orphan drug & rare disease - Accelerating access to therapeutic innovation'.
While the methodology remains the main focus of the programme, this year will also be the opportunity to address in particular the European Medicines Agency (EMA) tools in drug development and the issues around personalised medicine.